Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of 'no reflow' phenomenon

Abid R. Assali, Stefano Sdringola, Mohammad Ghani, Ali E. Denkats, Armando Yepes, George P. Hanna, George Schroth, Kenichi Fujise, H. Vernon Anderson, Richard W. Smalling, Oscar R. Rosales

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of 'no reflow,' ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the procedural outcomes of 79 patients who underwent percutaneous intervention in the context of acute myocardial infarction. Twenty-eight patients received no intracoronary adenosine, and 51 received intracoronary adenosine boluses (24-48 μg before and after each balloon inflation). Eight patients who were not given adenosine experienced no reflow (28.6%) and higher rates of in-hospital death, while only three of 51 patients (5.9%; P =0.014) in the adenosine group experienced no reflow. No untoward complications were noted during adenosine infusion. Intracoronary adenosine bolus administration during percutaneous intervention in the context of acute myocardial infarction is easy and safe and may significantly lessen the incidence of no reflow, which may improve the outcome of this procedure. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalCatheterization and Cardiovascular Interventions
Volume51
Issue number1
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

No-Reflow Phenomenon
Adenosine
Myocardial Infarction
Incidence
Cutaneous Administration
Economic Inflation

Keywords

  • 'No reflow' phenomenon
  • Intracoronary adenosine
  • Myocardial infarction
  • Percutaneous transluminal coronary angioplasty

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of 'no reflow' phenomenon. / Assali, Abid R.; Sdringola, Stefano; Ghani, Mohammad; Denkats, Ali E.; Yepes, Armando; Hanna, George P.; Schroth, George; Fujise, Kenichi; Vernon Anderson, H.; Smalling, Richard W.; Rosales, Oscar R.

In: Catheterization and Cardiovascular Interventions, Vol. 51, No. 1, 2000, p. 27-31.

Research output: Contribution to journalArticle

Assali, Abid R. ; Sdringola, Stefano ; Ghani, Mohammad ; Denkats, Ali E. ; Yepes, Armando ; Hanna, George P. ; Schroth, George ; Fujise, Kenichi ; Vernon Anderson, H. ; Smalling, Richard W. ; Rosales, Oscar R. / Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of 'no reflow' phenomenon. In: Catheterization and Cardiovascular Interventions. 2000 ; Vol. 51, No. 1. pp. 27-31.
@article{546c865356204c06ac635a2a82e87bd9,
title = "Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of 'no reflow' phenomenon",
abstract = "Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of 'no reflow,' ranging from 11{\%} to 30{\%}, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the procedural outcomes of 79 patients who underwent percutaneous intervention in the context of acute myocardial infarction. Twenty-eight patients received no intracoronary adenosine, and 51 received intracoronary adenosine boluses (24-48 μg before and after each balloon inflation). Eight patients who were not given adenosine experienced no reflow (28.6{\%}) and higher rates of in-hospital death, while only three of 51 patients (5.9{\%}; P =0.014) in the adenosine group experienced no reflow. No untoward complications were noted during adenosine infusion. Intracoronary adenosine bolus administration during percutaneous intervention in the context of acute myocardial infarction is easy and safe and may significantly lessen the incidence of no reflow, which may improve the outcome of this procedure. (C) 2000 Wiley-Liss, Inc.",
keywords = "'No reflow' phenomenon, Intracoronary adenosine, Myocardial infarction, Percutaneous transluminal coronary angioplasty",
author = "Assali, {Abid R.} and Stefano Sdringola and Mohammad Ghani and Denkats, {Ali E.} and Armando Yepes and Hanna, {George P.} and George Schroth and Kenichi Fujise and {Vernon Anderson}, H. and Smalling, {Richard W.} and Rosales, {Oscar R.}",
year = "2000",
doi = "10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0",
language = "English (US)",
volume = "51",
pages = "27--31",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of 'no reflow' phenomenon

AU - Assali, Abid R.

AU - Sdringola, Stefano

AU - Ghani, Mohammad

AU - Denkats, Ali E.

AU - Yepes, Armando

AU - Hanna, George P.

AU - Schroth, George

AU - Fujise, Kenichi

AU - Vernon Anderson, H.

AU - Smalling, Richard W.

AU - Rosales, Oscar R.

PY - 2000

Y1 - 2000

N2 - Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of 'no reflow,' ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the procedural outcomes of 79 patients who underwent percutaneous intervention in the context of acute myocardial infarction. Twenty-eight patients received no intracoronary adenosine, and 51 received intracoronary adenosine boluses (24-48 μg before and after each balloon inflation). Eight patients who were not given adenosine experienced no reflow (28.6%) and higher rates of in-hospital death, while only three of 51 patients (5.9%; P =0.014) in the adenosine group experienced no reflow. No untoward complications were noted during adenosine infusion. Intracoronary adenosine bolus administration during percutaneous intervention in the context of acute myocardial infarction is easy and safe and may significantly lessen the incidence of no reflow, which may improve the outcome of this procedure. (C) 2000 Wiley-Liss, Inc.

AB - Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of 'no reflow,' ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the procedural outcomes of 79 patients who underwent percutaneous intervention in the context of acute myocardial infarction. Twenty-eight patients received no intracoronary adenosine, and 51 received intracoronary adenosine boluses (24-48 μg before and after each balloon inflation). Eight patients who were not given adenosine experienced no reflow (28.6%) and higher rates of in-hospital death, while only three of 51 patients (5.9%; P =0.014) in the adenosine group experienced no reflow. No untoward complications were noted during adenosine infusion. Intracoronary adenosine bolus administration during percutaneous intervention in the context of acute myocardial infarction is easy and safe and may significantly lessen the incidence of no reflow, which may improve the outcome of this procedure. (C) 2000 Wiley-Liss, Inc.

KW - 'No reflow' phenomenon

KW - Intracoronary adenosine

KW - Myocardial infarction

KW - Percutaneous transluminal coronary angioplasty

UR - http://www.scopus.com/inward/record.url?scp=0033852140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033852140&partnerID=8YFLogxK

U2 - 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0

DO - 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0

M3 - Article

C2 - 10973014

AN - SCOPUS:0033852140

VL - 51

SP - 27

EP - 31

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 1

ER -